Rafael activates new site for Phase I of CPI-613 and bendamustine
https://globaldata.com/store/report/hodgkin-lymphoma-drugs-in-development-analysis/Rafael Pharmaceuticals has activated the second clinical trial site for its Phase I trial of CPI-613 in combination with bendamustine…
